The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up

Yapar, ZeynepKIBAR, MustafaYAPAR, A. FuatPAYDAŞ, SEMRAREYHAN, MehmetKara, OguzBUYUKDERELI, GulgunAydin, MEHMETKELLE, Aygul PolatÜNAL, İLKERDISEL, UmutYavuz, SinanSahin, BerksoyErkisi, Melek2020-10-292020-10-292010-01-01Yapar Z., KIBAR M., YAPAR A. F. , PAYDAŞ S., REYHAN M., Kara O., BUYUKDERELI G., Aydin M., KELLE A. P. , ÜNAL İ., et al., -The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up-, NUCLEAR MEDICINE COMMUNICATIONS, cilt.31, ss.59-66, 2010http://hdl.handle.net/20.500.12645/26273Background The management of the patients with carcinoma of an unknown primary represents a difficult challenge in oncology. F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) has provided new insights in the diagnosis, staging, and follow-up of oncological patients.The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-upArticleWOS:0002729150000107434909764010.1097/mnm.0b013e328332b340